Yeah MSB had a similar issue too I recall. Most shareholders were excited about the inclusion until the proverbial hit the fan when the big boys started to throw it around like a rag doll.
Different kettle of fish here though… MSB were only midway through a phase 3 trial of their cellular therapy Remestemcel-L when their inclusion happened - their primary product was unproven and invalidated at the time (still no FDA approval I think?)
Akida is a proven product now and has been endorsed by major players across multiple sectors which leads me to think that while we will still be subject to the games those big institutions play, the long term result will be much more positive for us as shareholders.
- Forums
- ASX - By Stock
- BRN
- BRN Ranked Now 181. S&P/ASX 200 Index Inclusion Imminent!
BRN Ranked Now 181. S&P/ASX 200 Index Inclusion Imminent!, page-14
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $451.3M |
Open | High | Low | Value | Volume |
23.0¢ | 24.0¢ | 21.5¢ | $2.863M | 12.69M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 136498 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 444756 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 86498 | 0.230 |
3 | 155000 | 0.225 |
16 | 439886 | 0.220 |
14 | 751341 | 0.215 |
35 | 871743 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 360988 | 11 |
0.240 | 791244 | 17 |
0.245 | 612347 | 15 |
0.250 | 151787 | 5 |
0.255 | 132485 | 7 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
BRN (ASX) Chart |